Tag: lexaria bioscience corp

May 11, 2020

Lexaria Bioscience Confirms Closing of US$2,039,228 Private Placement

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) confirms that its private placement financing.
May 4, 2020

Lexaria Bioscience Announces Over US$2,000,000 Private Placement

Lexaria Bioscience has entered into definitive agreements with certain qualified investors for the sale of share and warrants to purchase...
April 23, 2020

Lexaria Receives Notice of Allowance for New Patent and Awards Stock Options

Lexaria Bioscience (CSE:LXX) a global innovator in drug delivery platforms, has received a Notice of Allowance from the United States...
April 21, 2020

Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19

Lexaria (CSE:LXX) has filed a new patent application in the US describing the use of its DehydraTECH(TM) technology for the...
March 23, 2020

Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

Lexaria Bioscience has expanded the scope and activities of its 100%-owned subsidiary Lexaria Pharmaceutical Corp.
March 19, 2020

Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program

Lexaria Bioscience is commencing a program to study the benefits of Lexaria's DehydraTECHTM drug delivery platform in the fight against...
March 17, 2020

Lexaria Bioscience Announces Warrant Issuance

Lexaria Bioscience Corp. announces that on March 16, 2020 it issued share purchase warrants to one of its Canadian-based consultants.